Comparison of regorafenib and immunotherapy in colorectal cancer survival: A multicenter cohort study
{{output}}
Background: Real-world comparative outcomes of regorafenib versus immune checkpoint inhibitors (ICI) after chemotherapy in colorectal cancer (CRC) are limited. Me... ...
